cdmo.directory
← Compare landing

Charles River Laboratories vs Yapan Bio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/criver/yapan-bio

CategoryCharles River LaboratoriesYapan Bio
Listed sitebothcdmo
SummaryCharles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.Yapan Bio provides integrated process development, characterization, and GMP manufacturing for vaccines, monoclonal antibodies, gene therapy, and viral vector-based biologics, with capabilities up to 1000L bioreactor scale and BSL-2+ containment.
Services
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Technology Transfer
  • Formulation Development
  • Process Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Stability Testing & Storage
  • Cell-Line Development
  • Microbial Fermentation
  • Small Molecule Development & Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Stability Testing & Storage
  • Process Development
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Vaccine Manufacturing
  • Viral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Lyophilization (Freeze Drying)
  • Vial Filling
  • Microbial Fermentation
  • Recombinant Protein Manufacturing
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Vaccine
  • Biologics (Monoclonal Antibodies)
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Oncology
  • Immunology
  • Neurology
Data not yet provided.
Locations
  • Headquarters, United States
  • North America, North America, USA/Canada
  • Europe, Europe, Multiple
  • Asia, Asia, Multiple
  • North America, North America
  • Europe, Europe
  • Asia, Asia
  • 450 GMP Facility, Hyderabad, Telangana, India
  • Process Development Facility, Hyderabad, Telangana, India
  • 270 GMP Facility, Hyderabad, Telangana, India
Certifications
  • FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: Retrogenix® platform data support
  • PMDA · Identifier: Retrogenix® platform data support
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.